| Literature DB >> 23915335 |
Julie L Woods1, Sandra Iuliano-Burns2, Karen Z Walker3.
Abstract
BACKGROUND: This study examines associations between markers of nutritional status and lymphocyte subsets and seeks to determine if lymphocyte profile is predictive of survival in elderly Australians residing in aged care facilities. Aged yet still ambulatory subjects (n = 88, 73% female) living in low-level care and requiring minimal assistance were studied for 143 weeks. At baseline when participants were aged (mean ± SD) 86.0 ± 5.9 years, dietary intake was determined by 3-day weighed food record, body composition was assessed by dual energy X-ray absorptiometry (DXA) and a venous blood sample was taken.Entities:
Keywords: Aged care; Dietary intake; Lymphocyte subsets; Mortality
Year: 2013 PMID: 23915335 PMCID: PMC3751476 DOI: 10.1186/1742-4933-10-32
Source DB: PubMed Journal: Immun Ageing ISSN: 1742-4933 Impact factor: 6.400
Characteristics of the elderly study population (mean ± SD)
| | ||||||
|---|---|---|---|---|---|---|
| | | |||||
| Age (years) | 85.9 ± 5.3 | | | 86.3 ± 7.5 | | |
| Medical conditionsa | 5.0 ± 2.2 | | | 5.4 ± 2.3 | | |
| Medicationsb | 9.2 ± 4.4 | | | 9.5 ± 4.8 | | |
| Died (%) | 16 | | | 42** | | |
| Survival (weeks) c | 132.6 ± 3.3 | | | 109.0 ± 9.1 ** | | |
| Energy (kJ) | 6187 ± 1158 | 70 | | 7887 ± 1573*** | 50 | |
| Protein (g) | 53.1 ± 10.9 | 21 | | 69.7 ± 17.1*** | 41 | |
| (% E) | 14.7 ± 2.1 | | | 15.1 ± 2.6 | | |
| Fat (g) | 58.4 ± 14.1 | | | 72.9 ± 15.5*** | | |
| (% E) | 34.7 ± 3.5 | | | 34.3 ± 3.1 | | |
| Monounsaturated fat (g) | 19.5 ± 4.7 | | | 24.3 ± 5.4*** | | |
| Polyunsaturated fat (g) | 9.2 ± 2.8 | | | 10.2 ± 3.1 | | |
| Saturated fat (g) | 25.0 ± 7.2 | | | 32.3 ± 8.9*** | | |
| Total retinol (μg) | 1094 ± 320 | 1.8 | 59 | 1283 ± 335* | 4.5 | 46 |
| Folate (ug) | 197 ± 60 | 96 | | 258 ± 58*** | 86 | |
| Vitamin C (mg) | 122 ± 56 | | 32 | 124 ± 42 | | 41 |
| Iron (mg) | 8.1 ± 1.8 | 9 | | 10.2 ± 2.7** | | |
| Zinc (mg) | 6.5 ± 1.3 | 52 | | 8.6 ± 2.2*** | 91** | |
| Magnesium (mg) | 201 ± 41 | 96 | | 260 ± 75*** | 86 | |
| BMI (kg/m2) | 26.6 ± 4.4 | 3.3 | 20 | 25.9 ± 3.4 | 4.3 | 13 |
| Body fat (%) | 37.8 ± 7.9 | | | 26.1 ± 5.8*** | | |
| SMI% | 25.2 ± 3.7 | 41 | | 32.0 ± 2.6*** | 45 | |
| % with weight loss | 59.6 | | | 56.3 | | |
| Albumin (g/L) | 39.2 ± 3.4 | 8 | | 38.1 ± 3.8 | 22 | |
| Haemoglobin (g/L) | 126 ± 12 | 8 | | 131 ± 18 | 38** | |
| IL-6 (pg/mL) | 4.15 ± 2.4 | | 1.8 | 6.17 ± 33.6** | | 9.5 |
| CRP (mg/L) | 3.0 ± 2.5 | 40 | 8.7 ± 10.0* | 67* | ||
*P < 0.05, ** P ≤ 0.01, *** P < 0.001.
aNumber of medical conditions present from those listed under Methods.
bNumber of medications taken over the longer term. Medications for a temporary acute condition are not included.
cUntil death. Data presented as mean ± standard error for this variable only.
dFor dietary intake this is the % with intake below the estimated average requirement (EAR) for Australians or % above the recommended dietary intake (RDI) for Australians [45]; for BMI this is below 20 (kg/m2) and above 30 (kg/m2); for SMI% this is below 23.8% for women [44] and below 31.5% for men (unpublished but based on young male dataset as per [44]); for albumin this is the reference range provided by Network Pathology; for haemoglobin, CRP and IL-6 this is the reference range provided by Southern Cross Pathology.
Abbreviations: BMI body mass index, CRP C-reactive protein, IL-6 Interleukin 6, SMI (%) Percentage skeletal muscle, % E percentage of total energy.
Immune indices and lymphocyte subsets of the study population
| | | ||||||
|---|---|---|---|---|---|---|---|
| White blood cell count (×109/L) | 7.0 ± 1.6 | 1.6 | | 7.7 ± 2.3 | | 8.3 | 4–11 |
| Total lymphocytes (×109/L) | 1.6 ± 0.4 | 4.7 | | 1.5 ± 0.5 | 12.5 | | 1.0–4.0 |
| Neutrophils (×109/L) | 4.5 ± 1.3 | | | 5.1 ± 1.9 | | 8.3* | 2.0–8.0 |
| Monocytes (×109/L) | 0.6 ± 0.2 | | 6.2 | 0.7 ± 0.2 | | 12.5 | 0.0–1.0 |
| Count (×106/L) | 1174 ± 338 | 6.2 | | 1021 ± 355 | 16.7 | | 688–2445 |
| Percentage | 73.5 ± 8.5 | 4.7 | 9.4 | 70.8 ± 7.8 | 8.3 | 8.3 | 59–84 |
| Count (×106/L) | 824 ± 279 | | | 697 ± 239* | 8.3* | | 389–1569 |
| Percentage | 51.5 ± 10.5 | | 18.8 | 47.1 ± 7.3 | | 4.2 | 31–59 |
| Count (×106/L) | 329 ± 160 | 8 | | 292 ± 151 | 21 | | 168–894 |
| Percentage | 20.2 ± 7.9 | 12.5 | | 20.1 ± 8.1 | 12.5 | | 12–42 |
| 2.8 ± 1.4 | | | 2.8 ± 1.4 | | | | |
| Count (×106/L) | 145 ± 85 | 35.9 | | 109 ± 73 | 45.8 | | 98–597 |
| Percentage | 8.9 ± 4.6 | 29.7 | | 7.3 ± 3.9 | 41.7 | | 6–26 |
| Count (×106/L) | 266 ± 122 | 1.6 | | 291 ± 129 | | | 61–776 |
| Percentage | 16.7 ± 6.5 | 4.7 | 6.3 | 20.2 ± 7.9* | 4.2 | 12.5 | 7–28 |
| 0.35 ± 0.20 | 0.45 ± 0.22 * | ||||||
n = 88 (mean ± SD).
*P < 0.0.
Relationship between lymphocyte subset percentages and selected markers of nutritional status
| | 0.200 | | | 0.232 | | |||
| | 0.007 | | | 0.002 | | |||
| Age (yrs) | −0.21 | 0.06 | 4.2 | −0.72, 0.02 | −0.05 | 0.64 | 0.2 | −0.20, 0.13 |
| Sex | −0.18 | 0.18 | 2.1 | −9.75, 1.90 | 0.07 | 0.62 | 0.3 | −1.94, 3.25 |
| Medical conditionsb | −0.22 | 0.43 | 4.9 | −1.95, −0.03 | 0.01 | 0.89 | 0.0 | −0.40, 0.46 |
| Body fat (%) | 0.06 | 0.66 | 0.2 | −0.22, 0.36 | 0.30 | 0.02 | 6.1 | 0.02, 0.28 |
| Albumin (g/L) | −0.27 | 0.02 | 7.0 | −1.35, −0.14 | 0.37 | 0.001 | 13.7 | 0.21, 0.75 |
aPercentage of variation explained uniquely by the independent variable after adjustment.
bMedical conditions confined to those listed in Methods.
Relationship between risk of death and lymphocyte subset percentages (hazard ratios and 95% confidence intervals)
| No adjustment | 0.939 (0.896, 0.985)** | 1.004 (0.947, 1.065) | 0.774 (0.545, 1.098) | 0.938 (0.839, 1.049) | 1.094 (1.026, 1.167)** | 22.676 (3.492, 147.238)*** |
| Age and sex | 0.930 (0.881, 0.982)** | 1.014 (0.953, 1.080) | 0.726 (0.497, 1.061) | 0.954 (0.852, 1.069) | 1.084 (1.012, 1.161)* | 23.568 (3.112, 178.459)** |
| Age, sex, medical conditionsa | 0.922 (0.869, 0.977)** | 1.019 (0.954, 1.087) | 0.712 (0.481, 1.054) | 0.948 (0.844, 1.066) | 1.085 (1.012, 1.163)* | 27.132 (3.377, 217.978)** |
| Fully adjustedb | 0.919 (0.863, 0.978)** | 1.021 (0.955,1.091) | 0.697 (0.452, 1.075) | 0.982 (0.851, 1.133) | 1.085 (1.008, 1.168)* | 30.521 (3.151, 295.627)** |
aMedical conditions confined to those listed in Methods.
bAdjusted for age, sex, medical conditions, body fat percentage and serum albumin level.
*P < 0.05, ** P ≤ 0.01, *** P ≤ 0.001.